| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/23/2002 | WO2001047946A9 GFRα1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
| 05/23/2002 | WO2001041760A9 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 05/23/2002 | WO2000063204A3 Substituted azoles |
| 05/23/2002 | US20020062488 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus |
| 05/23/2002 | US20020062024 Hetero-tetrahydroquinolines |
| 05/23/2002 | US20020062023 Palau'amine; treatment of tumors, fungal infections and immunosuppressive affections. |
| 05/23/2002 | US20020062008 Novel human beta2 integrin alpha subunit |
| 05/23/2002 | US20020061929 Composition and method containing products extracted from commiphora sp. for prevention and treatment of abnormal cell growth and proliferation in inflammation, neoplasia and cardiovascular disease |
| 05/23/2002 | US20020061926 Pharmaceutical composition and method of using the same |
| 05/23/2002 | US20020061923 Diacid isoindoleine amide derivative |
| 05/23/2002 | US20020061920 Selected fused pyrrolocarbazoles |
| 05/23/2002 | US20020061916 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 05/23/2002 | US20020061914 Benzothiazole, benzooxazole and benzoimidazole derivatives as sodium or calcium channel modulators |
| 05/23/2002 | US20020061911 Enantiomers of 6-amino EM-12 and method of use |
| 05/23/2002 | US20020061908 S-(-)-9-fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methy l-1-oxo-1H,5H-benzo(i,j)quinolizine-2-carboxylic acid arginine salt microbiocides |
| 05/23/2002 | US20020061906 Aerosol compositions |
| 05/23/2002 | US20020061905 Ethers of 7-desmethylrapamycin |
| 05/23/2002 | US20020061904 Hydroxyesters of 7-desmethylrapamycin |
| 05/23/2002 | US20020061894 Treatment of Mycobacteria infection by administering (S)-lomefloxacin or a pharmaceutically acceptable salt thereof free of its (R)-stereoisomer |
| 05/23/2002 | US20020061892 Antiviral azaindole derivatives |
| 05/23/2002 | US20020061873 Having high bioavailability levels and reduced variability of bioavailability by use of dispersed, colloidal structures, colloids or analogous structures of the drug, a hydrophilic component, and a surfactant |
| 05/23/2002 | US20020061871 Photochemotherapeutic compositions |
| 05/23/2002 | US20020061858 4"-substituted-9-deoxo-9A-AZA-9A-homoerythromycin a derivatives |
| 05/23/2002 | US20020061853 Caspase inhibtors and uses thereof |
| 05/23/2002 | US20020061848 An specific polypeptides comprising a Chlamydia antigen and the use of such polypeptides for the serodiagnosis and treatement of Chlamydia infection |
| 05/23/2002 | US20020061844 Administering to the patient for inhibiting Fc receptor binding of immunoglobulin a compound selected from aromatic, heteroaromatic, cyclic, bicyclic and an amino acid derivative or salt |
| 05/23/2002 | US20020061843 Use of mCRP for delivery of materials into cells |
| 05/23/2002 | US20020061834 Human G-protein Chemokine receptor (CCR5) HDGNR10 |
| 05/23/2002 | US20020061585 Ribozymal nucleic acid |
| 05/23/2002 | US20020061569 Nuclelotide sequences for use in the prevention of proliferation of microorganisms |
| 05/23/2002 | US20020061545 Streptococcus pneumoniae antigens and vaccines |
| 05/23/2002 | US20020061540 Library; for use in drug screening and development |
| 05/23/2002 | US20020061517 Adenovirus carrying gag gene HIV vaccine |
| 05/23/2002 | US20020061333 Macrolide is not coated, is present in base form and is chosen from pristinamycin, azithromycin and clarithromycin, and contains at least one disintegrant |
| 05/23/2002 | US20020061314 Administering to animal live vaccine containing organisms to develop immunological response, maintaining animal free from drugs effective against infectious organism for period of one life or infectious cycle of organism, administering drug |
| 05/23/2002 | US20020061310 Compositions and methods for dendritic cell-based immunotherapy |
| 05/23/2002 | US20020061306 DNA sequences encoding proteins having ability to bind alpha 2-macroglobulin; expression vectors; immunology |
| 05/23/2002 | US20020061293 Transduced human hematopoietic stem cells |
| 05/23/2002 | US20020061281 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
| 05/23/2002 | CA2431651A1 Antifungal nail composition and method of use |
| 05/23/2002 | CA2429897A1 M. tuberculosis chaperonin 10 and uses thereof |
| 05/23/2002 | CA2429894A1 M. tuberculosis chaperonin 60.1 and uses thereof |
| 05/23/2002 | CA2429628A1 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| 05/23/2002 | CA2429411A1 Texaphyrin coordination compounds and uses thereof |
| 05/23/2002 | CA2429346A1 1-methylcarbapenem derivatives |
| 05/23/2002 | CA2429311A1 Heterocyclylalkyl piperidine derivatives, their preparation and compositions containing the same |
| 05/23/2002 | CA2429195A1 Immunoglobulin superfamily proteins |
| 05/23/2002 | CA2429144A1 Periplasmic domain of an enterobacterium omp protein and its use as carrier or adjuvant |
| 05/23/2002 | CA2429071A1 Processes for the preparation of carbapenem-type antibacterial agents |
| 05/23/2002 | CA2428863A1 Cysteine protease inhibitors |
| 05/23/2002 | CA2428753A1 Methods for inhibiting the transmission of hiv using topically applied substituted 6-benzyl-4-oxopyrimidines |
| 05/23/2002 | CA2428709A1 Association of calpain inhibitors and reactive oxygen species trapping agents |
| 05/23/2002 | CA2428527A1 (dihydro)isoquinoline derivatives as phosphodiesterase inhibitors |
| 05/23/2002 | CA2428519A1 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists |
| 05/22/2002 | EP1207203A2 DNA sequence and papillomavirus vaccine |
| 05/22/2002 | EP1206930A2 An oral treatment/care agent |
| 05/22/2002 | EP1206701A1 Antigenic components of selected indicator fungi and their use in methods and test kits |
| 05/22/2002 | EP1206582A1 Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission |
| 05/22/2002 | EP1206581A2 Methods of identifying anti-viral agents |
| 05/22/2002 | EP1206573A1 26 human secreted proteins |
| 05/22/2002 | EP1206563A1 Genetically altered dendritic cells transduced with adeno-associated virus (aav), methods of producing said cells and uses thereof |
| 05/22/2002 | EP1206562A2 Genetically engineered cell lines, and their uses, in particular for neurotoxicity testing |
| 05/22/2002 | EP1206557A2 Plant defensin variants |
| 05/22/2002 | EP1206553A2 Isomerase proteins |
| 05/22/2002 | EP1206550A1 Proteins derived from white spot syndrome virus and uses thereof |
| 05/22/2002 | EP1206549A1 Basb119 polypeptide and polynucleotide from moraxella catarrhalis |
| 05/22/2002 | EP1206548A1 Basb118 polypeptide and polynucleotide from moraxella catarrhalis |
| 05/22/2002 | EP1206541A1 Dendritic enriched secreted lymphocyte activation molecule |
| 05/22/2002 | EP1206529A2 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-BETA 1,3-N-ACETYLGALACTOSAMINE-ALPHA-R/(GlcNAc to GalNAc) BETA 1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3 |
| 05/22/2002 | EP1206528A2 Chimeric dna/rna ribozymes containing propanediol |
| 05/22/2002 | EP1206527A1 Treatment of inflammatory or malignant disease using dnazymes |
| 05/22/2002 | EP1206518A1 Color safe laundry methods employing zwitterionic formulation components |
| 05/22/2002 | EP1206484A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 05/22/2002 | EP1206476A1 9a-azalides with antibacterial activity |
| 05/22/2002 | EP1206470A2 Processes and intermediates for the preparation of isoxazolecarboxamides and analogues |
| 05/22/2002 | EP1206469A1 Antibacterial heterobicyclic substituted phenyl oxazolidinones |
| 05/22/2002 | EP1206465A1 Fatty acid synthase inhibitors |
| 05/22/2002 | EP1206464A1 Fatty acid synthase inhibitors |
| 05/22/2002 | EP1206463A1 Fatty acid synthase inhibitors |
| 05/22/2002 | EP1206455A1 ALPHAvBETA3 INTEGRIN INHIBITORS |
| 05/22/2002 | EP1206454A1 NOVEL INTEGRIN ALPHAvBETA3 INHIBITORS |
| 05/22/2002 | EP1206449A1 Lactam inhibitors of hepatitis c virus ns3 protease |
| 05/22/2002 | EP1206444A1 Compounds that inhibit tryptase activity |
| 05/22/2002 | EP1206285A2 Drug-carrier complexes and methods of use thereof |
| 05/22/2002 | EP1206283A2 Improved cellular uptake of bioactive agents |
| 05/22/2002 | EP1206281A1 Moxifloxacin formulation containing common salt |
| 05/22/2002 | EP1206279A1 Method for treating tnf-receptor type-2-induced diseases |
| 05/22/2002 | EP1206278A2 Peptide mixture and vaccine against a chronic viral infection |
| 05/22/2002 | EP1206273A2 Peptides that block viral infectivity and methods of use thereof |
| 05/22/2002 | EP1206272A1 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 05/22/2002 | EP1206267A1 Medicaments that contain xenogenic oligo- or/and polyribonucleotides |
| 05/22/2002 | EP1206258A1 Compositions containig esthers for treating parasitic infestations of organisms |
| 05/22/2002 | EP1206255A1 COMPOUNDS OBTAINED FROM i SALVIA SPECIES /i HAVING ANTIVIRAL ACTIVITY |
| 05/22/2002 | EP1206244A2 Aqueous pharmaceutical composition containing moxifloxacin or salts thereof |
| 05/22/2002 | EP1206233A2 Serine proteases |
| 05/22/2002 | EP1206189A1 Rotavirus vaccine formulations |
| 05/22/2002 | EP1152776B1 Biodegradable, injectable oligomer-polymer composition |
| 05/22/2002 | EP1042334B1 Acyl phosph(on)ate inhibitors of beta-lactamase |
| 05/22/2002 | EP0729463B1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents |
| 05/22/2002 | EP0665754B1 Antimicrobial peptides |